These results suggested that, similar to the results in vitro, miRNA-125a-5p can inhibit the progression of CCL4-induced liver fibrosis in mice by modulating the TGF-β/Smad signaling pathway and autophagy. This evidence concerns the gene CCL4 and Hepatic fibrosis.